The hunt for new cancer treatments is tough and pricey. But what if we could use old drugs in new ways? That's where machine learning (ML) comes in. It's a type of smart tech that can spot patterns and make predictions. Researchers are using it to find new uses for existing drugs. This could save ti
Revolution Medicines (RVMD) has been making waves in the stock market, reaching new heights. The company is valued at $15 billion and is focused on developing treatments for cancers caused by mutations in RAS proteins. This is a big deal because these types of cancers are tough to treat. The stock
In today's digital age, young doctors looking for breast surgery fellowships are turning to the internet. This shift is notable because earlier generations of doctors did not have this resource. However, the quality and accessibility of information on these fellowship websites vary greatly. The Soc
The U. S. Food and Drug Administration is looking to bring in a new boss for its drug approval team. This person, Richard Pazdur, is known for his work in cancer treatments. If he takes the job, he'll be in charge of making sure most medicines, from those you buy without a prescription to those need
Lung neuroendocrine neoplasms, or NENs, are not a single type of tumor but a group of different ones. This group includes well-differentiated neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs). Even though doctors have known about these tumors for a long time, they still find them tri
Cancer doctors in France face a tricky situation. They often mix up research goals with patient care. This mix-up is called therapeutic misconception (TM). It happens when people in studies think the main goal is to help them, not to find out new things for everyone. Oncologists deal with this a lo
Video calls are now a big deal in treating brain cancer in children. This isn't just a short-term trend. It's been going on for 20 years between two hospitals, one in Jordan and one in Canada. But it's not just them anymore. Since 2018, more hospitals in the region have joined in. They all talk abou
Thyroid cancer can be tricky. Most types grow slowly and aren't too aggressive. But some are more serious and spread quickly. This is where PET/CT scans come in handy. PET/CT scans combine two powerful tools. One shows how your body uses sugar. The other gives a detailed picture of your insides. To
PCSK9, a protein known for its role in managing cholesterol, is now under the spotlight for its potential influence on cancer outcomes. Recent research has dug into how PCSK9 behaves in different types of cancer, revealing a complex picture. In some cancers, like breast and ovarian, higher levels of
Cancer treatment is tricky. Doctors struggle with seeing deep into tissues. They also have trouble getting clear, real-time pictures of tumors as they change during treatment. Traditional imaging methods just don't cut it. They lack the detail and speed needed to track the dynamic tumor environm
